President Trump will introduce a "most favored nation" plan aimed at cutting Medicare drug prices by linking them to the ...

If you're following the GLP-1 (Ozempic and other prescription weight-loss medications) scene, you may have read that the FDA ...

Every plus-sized woman I knew as a teenager would attend WeightWatchers in phases; they’d go, lose weight, leave, put the ...

It was spurred by the Intercept’s disclosure of Musk’s hitherto-secret White House email address: [email protected]. When the Intercept first published Musk’s email address, on March 6, journalist ...

A new generation of GLP-1 drugs promising fast results continues to rock the weight loss industry, which has emphasized ...

WeightWatchers has filed for bankruptcy in the US as it struggles with debt and fierce competition from fat-loss jabs like ...

The maker of Ozempic and Wegovy expects lower sales and profit growth this year despite recent victories against compounders.

Novo Nordisk cut 2025 sales forecast citing competition from compounded versions of its Wegovy weight-loss drug. Invezz takes ...

Every year, hundreds of celebrities grace the iconic steps of the Metropolitan Museum of Art in New York City to showcase ...

Hims & Hers Health, Inc.'s subscriber growth, Novo Nordisk partnership, and FDA pill approval could boost financials. Click ...

Everyone's weight loss and health journey looks different, and these celebrities have spoken out about their own paths ...

Forget the gruelling gym workouts and strict diets. In Nairobi, a diabetes drug is all the rage for quick weight loss, but is ...